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Obesity is of global health concern. There are well-described inverse relationships between female pubertal
timing and obesity. Recent genome-wide association studies of age at menarche identified several obesity-related
variants. Using data from the ReproGen Consortium, we employed meta-analytical techniques to estimate the
associations of 95 a priori and recently identified obesity-related (body mass index (weight (kg)/height (m)2), waist
circumference, and waist:hip ratio) single-nucleotide polymorphisms (SNPs) with age at menarche in 92,116
women of European descent from 38 studies (1970–2010), in order to estimate associations between genetic vari-
ants associated with central or overall adiposity and pubertal timing in girls. Investigators in each study performed
a separate analysis of associations between the selected SNPs and age at menarche (ages 9–17 years) using
linear regression models and adjusting for birth year, site (as appropriate), and population stratification. Heteroge-
neity of effect-measure estimates was investigated using meta-regression. Six novel associations of body mass
index loci with age at menarche were identified, and 11 adiposity loci previously reported to be associated with
age at menarche were confirmed, but none of the central adiposity variants individually showed significant associ-
ations. These findings suggest complex genetic relationships between menarche and overall obesity, and to a
lesser extent central obesity, in normal processes of growth and development.
adiposity; body mass index; genetic association studies; menarche; obesity; waist circumference; waist:hip ratio;
women’s health
Abbreviations: BMI, body mass index; GIANT, Genetic Investigation of Anthropometric Traits; GWAS, genome-wide association
study(ies); SNP, single-nucleotide polymorphism.
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There have been dramatic changes in the prevalence of
obesity worldwide (1). Although higher-income countries
have been at the forefront of the obesity epidemic, develop-
ing countries have recently shown striking trends in obesity
(1, 2). Given that obesity may influence multiple physiologi-
cal functions in children and adolescents (3, 4), recent trends
may have lasting health impacts.
Age at menarche is considered a marker of hypothalamic-
pituitary-driven pubertal development in girls. Secular
trends towards earlier age at menarche began during the late
19th century in European countries (5). Early menarche is a
risk factor for increased adult adiposity (5), type 2 diabetes
(6, 7), breast cancer (8, 9), adolescent risk-taking behaviors
(10) and all-cause mortality (11).
Global and local obesogenic changes in the environment
and gene-environment interactions are hypothesized to
account for recent shifts in the distributions of both age at
menarche and adult obesity (5). A negative association
between childhood obesity and timing of menarche has been
described (12), and a recent Mendelian randomization study
suggested a possible causal relationship for this association
(13). Another study has shown that earlier menarche is asso-
ciated with adult obesity and predicts faster growth tempo
among a woman’s children (14).
Although the biological mechanisms of the relationship(s)
among increased childhood/adolescent adiposity, menarcheal
timing, and adult obesity have not been elucidated (3, 5), there
is evidence for genetic influences (15, 16). For instance, the fat
mass and obesity-associated gene (FTO) has been associated
with a decrease in age at menarche and increased body mass
index (BMI; weight (kg)/height (m)2) in childhood and adult-
hood (17). Recent genome-wide association studies (GWAS)
have identified several loci for age at menarche (18–22), several
of which were also associated with measures of obesity over
the life course (18, 23, 24). In a candidate single-nucleotide
polymorphism (SNP) study, Elks et al. (18) recently described
11 adiposity-related (BMI and waist circumference) loci that
were also associated with age at menarche (P < 0.05) among
women of European ancestry.
Two recent large GWAS from the Genetic Investigation of
Anthropometric Traits (GIANT) Consortium have substan-
tially expanded the number of validated overall (BMI) and
central adiposity (waist:hip ratio adjusted for BMI) loci by
reporting divergent sets of novel loci (18 and 13, respectively)
for these traits in persons of European ancestry (25, 26).
Genetic and environmental factors may contribute to increased
prepubertal adiposity, resulting in early menarche, shorter
stature, and increase postpubertal weight gain in women (5).
Thus, understanding the relationship between age at menarche
and obesity may have important implications for public health.
Therefore, we aimed to systematically investigate the associa-
tion between newly identified BMI-, waist circumference-, and
waist:hip ratio-related SNPs and age at menarche in 92,116
women of European descent.
MATERIALS ANDMETHODS
Population and outcome
Data from 38 studies in the ReproGen Consortium (see
Web Table 1 and the Web Appendix, available at http://aje.
oxfordjournals.org/) were included (18). Each study con-
sisted of women with genome-wide association genetic
information who identified themselves as being of European
descent and who reported their age at menarche as being
between 9 and 17 years of age (n = 92,116). Exclusion of
women with extreme ages at menarche was intended to
capture the normal range of pubertal variation by excluding
precocious or late-onset puberty or amenorrhea, which
might be due to rare genetic variants with large effect sizes
(e.g., Mendelian disorders).
The institutional review board of the University of North
Carolina at Chapel Hill reviewed and approved this research.
SNP selection
An a priori list of adiposity SNPs was compiled using
the National Human Genome Research Institute GWAS
catalog (27) for reported associations in the literature
(P < 1 × 10−5) with adult BMI, waist circumference, and
waist:hip ratio as of August 11, 2011 (25, 26, 28–37). Sixty-
eight of the resulting 95 candidate SNPs were previously
reported to be genome-wide significant (P < 5 × 10−8; Web
Table 2). When information on direction of effect was
absent in the literature, the direction of each SNP-adiposity
association was supplemented by publicly available data
from overall (BMI) or central (waist:hip ratio adjusted for
BMI) adiposity analyses, as appropriate (25, 26). Further
information on SNP selection is presented in Web Figure 1,
parts A–D.
Linkage disequilibrium among variants
Because of our reliance on multiple sources to generate
our candidate SNP list, some loci contained more than 1
SNP or were associated with more than 1 obesity-related
phenotype. The 11 adiposity SNPs previously reported to be
associated with menarche in the literature are presented in
Web Table 3 (18). An additional 14 SNPs at these 11 loci
and 70 SNPs at 60 loci not previously described as being
associated with menarche were then assessed for depen-
dence with respect to phenotype using publicly available
information derived from HapMap CEU data (38). Variants
that were within 500 kilobases of one another and in low
linkage disequilibrium with each other (r2 < 0.2) were con-
sidered to not represent the same underlying signal. If 2 or
more SNPs in linkage disequilibrium (r2≥ 0.2) were avail-
able, the most replicated SNP in the GWAS literature (27)
was selected to represent the region (Table 1, Web Table 4).
The other SNPs are shown in Web Table 5.
Only 1 locus (defined as ±500 kilobases in size) had evi-
dence of 2 signals based on our above methodology: the
brain-derived neurotrophic factor gene (BDNF) (Table 1).
Multiple SNPs at the melanocortin 4 receptor (MC4R) and
neurexin-3 (NRXN3) loci have been reported in association
with various adiposity phenotypes (25, 31). rs489693 and
rs12970134 at the MC4R locus were considered to represent
waist circumference and BMI, respectively (Web Table 4),
whereas NRXN3 was considered to represent BMI only (31).
Therefore, rs10150332 is presented in Web Table 4 and a
second NRXN3 variant, rs10146997, in perfect linkage
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Table 1. Associations Between Body Mass Indexa and Single-Nucleotide Polymorphisms at Novel Age-at-Menarche Loci and Loci Previously Reported to Be Associated With Age at
Menarche (P < 0.05/95b) Among Women (n≤ 92,105) From 38 Studies in the ReproGen Consortium, 1970–2010
Reference SNP
No.
Chromosome Position,c base pairs Nearest Gene No. of Studies No. of Women
Allele Fixed Effects
Coded Other Coded Frequency
Estimate
(SE), daysd
P Value P for
Heterogeneity
Novel AAM Loci
rs1514175 1 74,764,232 TNNI3K 37 89,922 A G 0.43 −12.2 (2.4) 4.0 × 10−7 0.07
rs713586 2 25,011,512 RBJ 38 92,078 T C 0.53 11.7 (2.4) 8.4 × 10−7 0.82
rs887912 2 59,156,381 FANCL 38 92,063 T C 0.28 −11.1 (2.7) 3.8 × 10−5 0.91
rs10769908d 11 8,440,665 STK33 36 86,344 T C 0.48 9.6 (2.4) 7.8 × 10−5 0.98
rs2241423 15 65,873,892 MAP2K5 38 92,085 A G 0.22 13.1 (2.9) 6.1 × 10−6 0.25
rs12444979 16 19,841,101 GPRC5B 37 88,557 T C 0.13 13.5 (3.7) 2.6 × 10−4 0.20
Previously Reported AAM Loci e
rs2568958 1 72,537,704 NEGR1 38 92,071 A G 0.61 −13.4 (2.4) 3.3 × 10−8 0.41
rs543874 1 176,156,103 SEC16B 38 92,053 A G 0.81 19.2 (3.1) 6.7 × 10−10 0.81
rs7561317e 2 634,953 TMEM18 38 92,083 A G 0.17 18.4 (3.2) 8.5 × 10−9 0.70
rs9816226 3 187,317,193 ETV5 38 92,067 A T 0.18 12.5 (3.1) 7.0 × 10−5 0.74
rs7481311e 11 27,539,705 BDNF f 37 89,927 T C 0.23 −12.7 (2.9) 1.3 × 10−5 0.14
rs6265d,e 11 27,636,492 BDNF f 37 89,934 T C 0.18 13.6 (3.2) 1.7 × 10−5 0.51
rs8050136e 16 52,373,776 FTO 37 89,844 A C 0.40 −16.7 (2.4) 9.5 × 10−12 0.23
rs29941 19 39,001,372 KCTD15 38 92,065 A G 0.32 11.4 (2.6) 9.3 × 10−6 0.11
Abbreviations: AAM, age at menarche; BMI, body mass index; GIANT, Genetic Investigation of Anthropometric Traits; SE, standard error; SNP, single-nucleotide polymorphism.
a Weight (kg)/height (m)2.
b All associations shown had a P value less than a Bonferroni correction for 95 tests or P < 0.00053.
c Position from HapMap Build 36 (http://hapmap.ncbi.nlm.nih.gov/).
d The T allele for rs6265 at BDNF has been associated with increases in both menarche and BMI. All other SNP associations in the table have inverse associations for the same coded
allele with menarche and BMI from the literature. However, information on direction of association with BMI for rs10769908 at STK33 was supplemented by publicly available data from the
GIANT Consortium as well as information from another SNP (rs4929949 at RPL27AI, shown in Web Table 4) in linkage disequilibrium (r2 = 0.97).
e Unlike those listed in Web Table 3, these SNPs have not previously been reported to be associated with age at menarche. However, they were generally in linkage disequilibrium (r2≥ 0.2)
with other SNPs previously reported to be associated with both adiposity traits and menarche (18) (see Web Table 3). Nonetheless, the associations presented here are larger by up to
5,389 additional samples and now include heterogeneity P values. Additional SNP associations at 3 of these previously reported menarche-adiposity loci are reported in Web Table 4
(TMEM18, BDNF, and FTO), because they were in linkage disequilibrium with the noted SNPs (r2≥ 0.2).



























































disequilibrium with rs10150332 (r2 = 1.0) is presented in
Web Table 5.
Quality control
This study used existing genetic data from the ReproGen
Consortium. Study-specific call rates, minor allele frequen-
cies, Hardy-Weinberg equilibrium, and other quality control
measures are described briefly in the Web Appendix and
more in depth elsewhere (18). Imputed SNPs used in analy-
ses were required to have a quality score greater than 0.3
(MACH software, variable rsq (www.sph.umich.edu/csg/




Investigators in each participating study performed a
linear regression of age at menarche (in years) on the
number of coded alleles per SNP, while adjusting for birth
year, population stratification, and study center (as applica-
ble). We tested between-study heterogeneity for all SNP
associations and considered a given association potentially
heterogeneous when the heterogeneity P value was less than
0.10.
Study-specific results were meta-analyzed using inverse
variance weighting fixed-effect meta-analysis (METAL)
(39). All estimated changes in age at menarche per allele
(i.e., slopes) were then converted to represent changes in
menarche onset in days per allele (365.25βyear = βdays) and
are referred to as effect estimates.
In the presence of potential heterogeneity, we used
random-effects meta-analysis and performed meta-regression
using restricted maximum likelihood in Stata 11 (StataCorp
LP, College Station, Texas). The following study-specific
characteristics were used (Web Table 1): population-based
cohort study of unrelated individuals (vs. non-population-
based/family study), population isolate (vs. nonendogamous
source population), European country (vs. United States/
Australia) with an obesity epidemic (vs. without an obesity
epidemic, defined as <20% of the adult female population
being obese in the most recent publicly available survey
(40)), coded allele frequency (0–1), imputed SNP (vs. geno-
typed SNP), imputation quality score (0–1 for imputed SNP,
1 for genotyped SNP), age at report (mean and standard devi-
ation), and birth year (mean and standard deviation). We also
performed a meta-regression of age at menarche on birth year
to account for differences in the precision of study-level
average menarcheal ages.
Multiple testing
We performed a Bonferroni correction for all estimated
SNP associations (n = 95) without consideration of the adi-
posity phenotypes, genetic signal dependence, or previous
reports of significance in the literature (18). Therefore, we
considered SNP associations not previously described as
involving additional associations with menarche as signifi-
cant if their 2-sided P value was below 0.0005. For the 11
adiposity SNPs previously reported to be associated with
menarche, we considered directionally consistent effects as
confirmatory of the results of Elks et al. (18), because of the
overlap of approximately 87,800 stage 1 samples in this
study and the previous report.
Alternative multiple testing methods were considered
comprising 1 additional family-wise error rate method and 2
false discovery rate methods (Web Appendix).
Cumulative genetic effects
Genetic risk scores for overall (BMI) and central (waist
circumference/waist:hip ratio) adiposity were calculated
using comparable methods (Web Appendix) to investigate
the cumulative effects of these variants on age at menarche
(41, 42).
Pathway and protein-protein interaction analyses
As described in the Web Appendix, we used 3 methods to
further investigate biological processes, based on observed
patterns of association (25, 43–45).
RESULTS
Menarche secular trends and birth cohort effects
The mean age at menarche among the 38 studies, which
collected data between 1970 and 2010, ranged from 12.4
years in the Women’s Genome Health Study to 13.7 years in
the CROATIA-Korcula and KORA studies (Web Table 1).
The average age at which women reported having under-
gone menarche ranged between 12.7 years (Western Austra-
lian Pregnancy Cohort) and 69.6 years (Rotterdam Study I).
No study measured age at menarche prospectively in the
entire sample. However, through parent-assisted reports,
investigators in the Western Australian Pregnancy Cohort
assessed menarche prospectively in the majority of its
sample (596 of 614 girls) at an average age of 12.7 years.
Similarly, in the 1958 British Birth Cohort, researchers
assessed menarche during adolescence at an average of 16.1
years—however, they did so retrospectively.
Secular trends at the population level exist for age at men-
arche (5). A similar trend is shown in the ReproGen Consor-
tium (Figure 1), in which studies with more recent birth years
also had lower average ages of menarche (a 14.0-day decline
in average age at menarche per decade; estimated in a meta-
regression not shown). The oldest birth cohort was the Nurses’
Health Study, and the youngest was the Western Australian
Pregnancy Cohort (Web Table 1).
Genetic findings
Among the 60 adiposity loci not previously associated
with age at menarche, 6 BMI loci contained at least 1 SNP
that was significantly associated with age at menarche after
adjustment for multiple testing (Table 1; Web Table 6),
whereas 54 loci showed weaker evidence of association
(P≥ 0.0005; Web Figure 1B and Web Tables 4 and 5). No
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waist circumference or waist:hip ratio SNPs were signifi-
cantly associated with age at menarche.
All 11 adiposity loci previously reported to be associated
with age at menarche were also associated with menarche in
this study (P < 0.05), of which 9 SNP associations were sig-
nificant after Bonferroni correction (Web Table 3). Seven
loci contained at least 1 additional statistically significant
SNP (P < 7 × 10−5; Table 1) in high linkage disequilibrium
with the index SNP.
Description of 6 BMI loci with novel menarche
associations
Of the significant BMI variants (shown in Table 1 by
chromosomal location and in Web Figure 2 by decreasing
magnitude of effect), GPRC5B on chromosome 16 showed
the strongest magnitude of effect on age at menarche
(rs12444979-T; a 13.5-day increase (Web Figure 2A)). A
signal atMAP2K5 on chromosome 15 had the next strongest
effect (rs2241423-A; a 13.1-day increase (Web Figure 2B)).
Both coded alleles confer an increase in age at menarche and
a decrease in BMI (25).
rs1514175-A at TNNI3K, previously reported to increase
adult BMI (25), was associated with menarche onset that
was decreased by 12.2 days, but the locus showed evidence
of between-study heterogeneity (P = 0.07). As compared
with the fixed-effect estimate (Web Figure 2C), the random-
effects estimate was larger and more imprecise (decreases in
menarche per A allele were 12.2 days (95% confidence inter-
val: –16.8, –7.7) and 14.6 days (95% confidence interval: –21.2,
–8.0), respectively). In a meta-regression with study-specific
characteristics, we estimated the variance between studies
(τ2) to be zero across the 37 studies with information on
rs1514175. Moreover, it indicated that population-based
studies or those with genotyped data tended to have smaller
effect estimates as compared with non-population-based
designs or studies with imputed data (P≤ 0.01). No other
study characteristics appeared to significantly predict study-
specific effect estimates (P≥ 0.05).
The association of each rs713586-T allele at the RBJ
locus was estimated to reflect an 11.7-day increase in menar-
che (Web Figure 2D) and a decrease in BMI (25). rs887912
at FANCL was associated with an 11.1-day decrease in men-
arche per T allele (Web Figure 2E) and has been reported to
be associated with increased BMI (25). Lastly, rs10769908
(near STK33) was associated with an increased age at menar-
che of 9.6 days for each T allele (Web Figure 2F). Although
the direction of effect of rs10769908 on BMI was not pub-
lished (37), publicly available data from the GIANT Consor-
tium indicated that each additional T allele was associated
with decreased BMI (25). Moreover, rs10769908 was in
high linkage disequilibrium (r2 = 0.97) with another SNP,
rs4929949, which had a similar magnitude and precision
(Web Table 5) as rs10769908 and has a documented nega-
tive effect on BMI (25). Each of these SNPs (or a proxy
thereof ) showed inverse associations with BMI and age at
menarche.
Loci with no statistically significant evidence
of association
Fifty-four adiposity loci containing 55 independent
genetic signals and 8 dependent genetic signals (Web
Tables 4 and 5, respectively) were not associated with age at
menarche after the Bonferroni correction. Of these 54 loci,
12 BMI and waist circumference loci contained at least 1
nominally significant SNP association (P < 0.05; Web
Tables 4 and 5)—10 loci having inverse associations and 2
loci having parallel effects on adiposity and menarche.
Previously reported menarche-adiposity loci
Of the 11 previously reported adiposity-menarche loci (18),
all index SNPs were significant (P < 0.05), were directionally
consistent, and had inverse or unknown (e.g., rs11084753)
effects on adiposity and menarche (Web Table 3). Nine index
SNPs also had evidence of association with age at menarche
below a Bonferroni correction (P < 0.0005), and an additional
index SNP at ETV5, rs7647305, was in tight linkage disequili-
brium (r2 = 0.79) with another ETV5 SNPwith strong evidence
of association (rs9816226; Table 1).
In addition to the 11 index SNPs previously described
(18), 7 loci (NEGR1, SEC16B, TMEM18, ETV5, BDNF,
FTO, and KCTD15) contained 14 SNP associations (8 are
presented in Table 1 (P < 7 × 10−5) and 6 in Web Table 5
(P < 0.03)). Notably, all additional BMI SNPs at BDNF were
associated with similar magnitudes of effect (P< 1.7 × 10−5;
Table 1 and Web Table 5), but linkage disequilibrium
patterns indicated that rs10767664 and rs6265 (r2 = 0.77,
P < 0.021) and rs925946 and rs7481311 (r2 = 0.57, P <
0.017) were in tighter linkage disequilibrium within them-
selves than with the other group (r2 < 0.15). Similar to previ-
ous work (18), 4 index SNPs at or near GNPDA2, TFAP2B,
Figure 1. Secular trends in mean age at menarche among 38
studies of women of European descent in the ReproGen Consortium,
by continent of origin (Europe (n = 28; white circles) or United States/
Australia (n = 10; black diamonds)). The ReproGen Consortium
studies were conducted in Europe, the United States, and Australia
between 1970 and 2010 (see Web Table 1). The best-fit line includes
all studies and corresponds to an 11.2-day decline in age at
menarche per decade.
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MSRA, and FAIM2 were confirmed to be associated with age
at menarche (Web Table 3), and 4 BMI loci (MTCH2,
MC4R, SH2B1, NRXN3) were not associated with age at men-
arche.
Multiple testing
Because of the highly nonuniform distribution of P
values among the 95 candidate SNP associations (Web
Figure 3, parts A and B), various approaches were con-
trasted. Holm P values were comparable to Bonferroni’s
(Web Tables 7 and 8). In contrast, the false discovery rate
and positive false discovery rate, which yielded less conserv-
ative P values, increased the number of significant associa-
tions to 35 and 45, respectively.
Cumulative genetic effects
Both overall (BMI) and central (waist circumference/
waist:hip ratio) genetic risk scores were normally distributed
in the Atherosclerosis Risk in Communities and Women’s
Health Genome studies (Web Figure 4, parts A–F). The
BMI genetic risk score was associated with a larger decline
in menarche than the waist circumference/waist:hip ratio
genetic risk score after adjustment for birth year, population
stratification, and center (as appropriate) (Figure 2). Although
the association between BMI genetic risk score and menar-
che was significant in each study and when we used SNP-
level data to estimate the genetic risk score (P < 4 × 10−8),
the waist circumference/waist:hip ratio genetic risk score was
not significant in the Atherosclerosis Risk in Communities
Study, probably because of imprecision (P = 0.3). Results did
not change considerably in either of the 2 studies when no
adjustments for population stratification were made (Web
Figure 4, parts A and D).
Pathway and protein-protein interaction analyses
MAGENTA pathway analyses (http://www.broadinstitute.
org/mpg/magenta/) identified several genes in pathways near
BMI loci that were associated with menarche in our study
(Web Table 9), but genes near these loci did not significantly
cluster in particular BMI pathways according to g:Profiler
(http://biit.cs.ut.ee/gprofiler/) (Web Tables 10–13). Protein-
protein interaction analysis revealed 6 direct interactions
among the proteins coded by nearby genes of menarche-
associated adiposity loci (P < 0.0005; Web Figure 5); none
of these genes overlapped with any of the genes identified
by the MAGENTA pathway analysis.
DISCUSSION
Recent studies of the genetics of menarche have agnosti-
cally focused on the discovery of novel loci (18–22). We
implemented a candidate-SNP approach to test the hypothe-
sis that adiposity loci are also associated with age at menar-
che. We aimed to characterize the SNP effects and evaluate
potential heterogeneous effects that may be represented by
loci influencing early growth and development and thus
both adiposity and menarche.
We identified 6 adiposity loci (7 SNPs; Web Figure 1A)
associated with age at menarche that have been described in
a recent GWAS of adult BMI as part of the GIANT Consor-
tium (25), which overlaps substantially with the cohorts of
the ReproGen Consortium (approximately 82,000 samples).
Eleven previously described adiposity-menarche loci (11
SNPs; Web Table 3) were confirmed (18), and an additional
14 SNPs were found to be associated with age at menarche
at these loci (Web Figure 1C). Interestingly, all 17 loci
exhibited inverse relationships with adiposity and menarche
timing and were related to BMI (or waist circumference
unadjusted for BMI). One such locus showed evidence of
heterogeneity, which appeared to be primarily driven by
data quality. Therefore, our study brings the known number
of such loci to 17 (32 SNPs) and implies that there are exten-
sive genetic influences on overall adiposity and pubertal
development.
Because of the known relationship between central adi-
posity, elevated androgen exposure, and reduced ovulatory
function, as in polycystic ovary syndrome (46), we had pre-
dicted that genetic variants associated with increased central
adiposity would be associated with menarche timing. Genetic
loci associatedwith thedistributionofbody fat ingluteal/femoral
regions may possibly influence menarche, since fat in these
Figure 2. Effect estimates for the association between overall and
central adiposity genetic risk scores (GRS) and age at menarche in
the Atherosclerosis Risk in Communities (ARIC) Study (n = 4,775;
bars with vertical thin stripes) (52), the Women’s Genome Health
Study (WGHS) (n = 22,863; white bars) (53), and 38 studies in the
ReproGen Consortium, using SNP-level fixed-effect estimates from a
sample of up to 92,105 women (bars with diagonal thick stripes) (for
references, see Web Appendix). The ARIC and WGHS studies were
conducted in the United States in 1987–1989 and 1992–1994,
respectively; other ReproGen studies included in the SNP-level fixed-
effect estimates were conducted in Europe, the United States, and
Australia between 1970 and 2010 (see Web Table 1). Cumulative
genetic risk was defined as the sum of the menarche risk alleles per
individual. Genetic risk scores were calculated for overall (BMI) and
central adiposity (WC/WHR) variants separately. Adjustments were
made for birth year, population stratification, and center (appropriate
for the ARIC Study only). Further details about the use of SNP-level
fixed-effect estimates can be found in the Web Appendix. Bars, 95%
confidence interval. BMI, body mass index; SNP, single-nucleotide
polymorphism; WC, waist circumference; WHR, waist:hip ratio.
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regions is more readily mobilized for reproductive function
than abdominal fat depots (47, 48). However, our study shows
a lack of individual SNP associations of central adiposity
loci (independent of BMI)with age atmenarche but some evi-
dence of a cumulative association using the genetic risk score
(Figure 2). The 2 waist circumference loci (TFAP2B,MSRA)
previously reported to be associated with age at menarche
were bothunadjusted forBMIand thereforemay inadvertently
represent BMI genetic signals (33). In fact, the TFAP2B locus
has recently also been associated with adult BMI (25). These
findings may suggest that the high energy cost of pregnancy
and lactation (which becomes an issue as soon as a female
reaches menarche and can conceive) drives a stronger shared
genetic basis between overall adiposity and menarche than
with fat distribution (49, 50).
Because of the candidate-SNP design of our study, we
observed a skewed distribution towards lower P values. There-
fore, we applied alternative multiple testing adjustments to
our data, including the false discovery rate, which appeared
to be the best alternative to Bonferroni correction. Using this
method, we could expect 1–2 of our 35 positive findings to
be false. Nonetheless, such less conservative multiple correc-
tion methods may be advantageous in prioritizing specific
genetic variants for future studies of the genetics of early growth
and development.
Searching known biological pathways and protein-protein
interactions for loci influencing both adiposity and menarche
was inconclusive, since there was no overlap between the
outcomes of the various approaches. In part, this may be due
to limited knowledge of the relevant biology. Temporal
action earlier in the life course could also drive the associa-
tion with menarche of some adiposity variants over others in
the same pathways.
Our study had several strengths, including its large sample
size, availability of detailed study characteristics, and evalu-
ation of between-study heterogeneity. We used a conserv-
ative threshold for significance but also investigated the
impact of alternative multiple testing adjustments.
However, our study was restricted to women of European
descent, and thus the results may not be generalizable to
pubertal timing in males or other ancestral populations. Our
study may have been subject to the “winner’s curse,” and
the findings should be replicated in future studies. Even
though we had greater than 80% power to detect 93 of 95
nominal associations (see Web Appendix and Web Figure 6,
parts A and B), this number decreased substantially after
Bonferroni correction—especially for variants of low fre-
quency or weak effects. This study primarily relied on a ret-
rospective measure of age at menarche. However, the
reliability of self-reported menarche is generally considered
to be good as a major milestone for girls (51). The resulting
misclassification is probably independent of both genotype
and childhood BMI. Given the effect of earlier menarche on
all-cause mortality, there is potential for selection bias
among older cohorts of women in this meta-analysis. None-
theless, we observe that these common genetic variants have
modest effects on age at menarche ( <20-day decline in men-
arche per risk allele) generally with little heterogeneity
across studies. Moreover, at TNNI3K, age at report was not a
significant predictor of effect heterogeneity. Lastly, we were
unable to assess whether a variant’s effects on menarche and
adiposity resulted from pleiotropic or mediated effects, since
data on adiposity measures were not available for most
studies at the time of menarche.
Our study expands current knowledge on menarche-
associated SNPs and may help to increase understanding of
how adiposity variants play a role in growth and develop-
ment during puberty. Its findings do not strongly support the
existence of associations between menarche and central
obesity, a risk factor for metabolic disease. Instead, they
indicate that overall adiposity is a phenotype more closely
related to normal growth and development. Because loci that
increase adiposity and decrease age at menarche may have
particularly strong effects on adult-onset outcomes related to
cumulative estradiol and fatness exposures, this study and
others like it may contribute to the identification of genetic
variants that are important for outcomes such as breast
cancer (8) or cardiovascular diseases.
Future researchers can investigate the biological mecha-
nisms of these variants using observational and animal
studies. In addition, longitudinal study designs may help to
identify temporal relationships of pre- and postpubertal BMI
with age of menarche as well as optimal intervention
windows. Understanding the complex interface between
childhood/adolescent adiposity, early menarche, and adult
obesity may help with the investigation of growth and devel-
opmental trajectories, which influence disease throughout
the life course.
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